跳至主要内容
临床试验/JPRN-UMIN000024180
JPRN-UMIN000024180已完成未知

Activated microglia and alpha 7 nicotinic acetylchorine receptors in schizophrenia: A PET study - Evaluation for activated microglia and alpha 7 nicotinic receptors using PET in schizophrenia patients

Hamamatsu University School of Medicine, Department of Psychiatry0 个研究点目标入组 40 人开始时间: 2016年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

The schizophrenia group showed an increase in the binding potential of MeQAA in the whole brain compared to the healthy group. On the other hand, the binding potential of DPA713 was not significantly different between the two groups. In the future, we plan to conduct a correlation analysis of the binding potential of MeQAA with symptom severity and the binding potential of DPA713, as well as an ROI analysis by defining regions of interest, and submit the results to an international journal.

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • - With past or current history of serious medical illness and/or brain organic diseases - History of alcoholics or substance abuse or addiction - In pregnancy - No family support

研究者

发起方
Hamamatsu University School of Medicine, Department of Psychiatry

相似试验

Activated microglia and alpha 7 nicotinic... | 临床试验